Amidox, an Inhibitor of Ribonucleotide Reductase ...

4 downloads 49 Views 1MB Size Report
8 & 9. pp. 1541- 1544, 2004. Amidox, an Inhibitor of Ribonucleotide Reductase,. Potentiates the Action of Ara-C in HL-60 Human. Promyelocytic Leukemia Cells.
M~Bib

eDoc FaxService: +49.89.2805307 (Ci)

NUCLEOSIDES. NlJCtEOTIDES & NUCLF.IC ACIDS Val. 23. Nos. 8 & 9. pp . 154 1- 1544, 2004

Amidox, an Inhibitor of Ribonucleotide Reductase, Potentiates the Action of Ara-C in HL-60 Human Promyelocytic Leukemia Cells W. Bauer,* Z. Horvath, T. H&htl, Po Saiko, D. Karl, M. Fritzer-Szekeres, and T. Szekeres Clinieal Institute of Medieal and Chemical Laboratorydiagnostics. Univcrsity of Vienna, Vienna, Austria

ABSTRACT Amidox O .4-dihydroxybenzamidoxime), a new polyhydroxy-substituted benzoie acid derivative. is a polen! inhihitor or the enzyme ribonucle.otide reduclase (RR), which cataly~cs thc de novo synthesis of DNA. RR is considered to be an excellent target for cancer chemolherapy. In thc prescnt study we invcstigated the antineopla.~tic effects of Amido)( alone and in combinatioll with Arabinofuranosylcytosine (Ara-C) in HL-60 human promyelocylic leukemiil cells. Jn growlh inhibition experimenls Amidox yieldcd an lC~n of JO ~tM . colony forrnation was inhibite.d at an IC 50 of 20 11M as dClennincd by a soft agar a~say . Exposure of the edls 10 75 and 100 ~tM Arnidox fo!" 24 hours was shown 10 signiticantly deerease intraceUular dCTP, dGTP and dATP pools. whereas dTTP conccntration incrcased. as dcterrnined by HPLC. TIle wmbination of Amidllx with Ara-C yielded Illore thall additive eytotoxie effects both in growth inhihiti()n assays and in soft agar assays. We could show that-after

*Correspondcnce: W. Bauer. Clinical Institute of Mediea! and Chernieal Laboratorydiagnostics. University of Vienna. Vicnna, Austria. 1541 DOI: lO.IOH t/NCN·2UOO27766 Copyright () 2004 by Marcel Dekkcr. Ine.

1525·7770 (Print): \532-2335 (Dnline) www.dckker.com

M~Bib

D3

eDoc FaxService: +49.89.2805307 (Ci)

Bauer et al.

1542

preincubating the ceHs with 75 and 100 11M Amidox and ~uh ~equent exposurc La AraC- intracellular Ara-CTP levels increased by 576% and 1143%, rcspective1y . In conclusion, Amidox might offer an additional option for the treatment of leuk.emia